Profile

    Corporate information

    Official name
    Avelas Biosciences Incorporated

    Registration country
    Investment activity status
    Active investor

    Company type

    Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons.

    Funding rounds

    Series C USD 20,000,000


    USD 20,000,000 (18 Aug 2016)

    Profile Country Notes
    Pharmastandard Led the round.
    Alexandria Venture Investments Round participant.
    Avalon Ventures United States Round participant.
    Bregua Corp Round participant.
    Ervington Investments Round participant.
    WuXi Healthcare Ventures Round participant.

    Series B USD 7,400,000


    USD 7,400,000 (10 Sep 2014)

    Profile Country Notes
    Avalon Ventures United States
    Torrey Pines Investment Specialty life-science investment company located in San Diego. United States

    Series B USD 6,800,000


    USD 6,800,000 (9 Jan 2014)

    Profile Country Notes
    Avalon Ventures United States Led the round. Jay B Lichter
    Torrey Pines Investment Specialty life-science investment company located in San Diego. United States Round participant.
    WuXi AppTec Co Ltd WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company. Round participant.

    Series A USD 7,650,000


    USD 7,650,000 (6 Dec 2012)

    Profile Country Notes
    Avalon Ventures United States Jay B Lichter

    Current and past shareholders

    Investor Contacts Round
    Alexandria Venture Investments
    Series C
    Avalon Ventures logo Avalon Ventures
    +1 (858) 348-2180
    Series A
    Series B
    Series C
    Bregua Corp
    Series C
    Ervington Investments
    Series C
    Pharmastandard
    Series C
    Torrey Pines Investment logo Torrey Pines Investment
    Specialty life-science investment company located in San Diego.
    +1 (858) 724-0581
    Series B
    WuXi AppTec Co Ltd
    WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company.
    Series B
    WuXi Healthcare Ventures
    Series C